BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Pharmacol Ther. Sep 5, 2026; 17(3): 120768
Published online Sep 5, 2026. doi: 10.4292/wjgpt.120768
Serial Bogota bag tightening: A pragmatic advance in open abdomen management for resource-limited settings
Gemechu Dereje Feyissa
Gemechu Dereje Feyissa, Department of Public Health, Faculty of Health Sciences, Rift Valley University, Adama 1715, Oromīa, Ethiopia
Author contributions: Feyissa GD conceptualized the editorial, drafted and revised the manuscript, and approved the final version.
AI contribution statement: I used AI based language polishing and grammar checking tools (e.g., Grammarly) to assist in improving the clarity, fluency, and grammar of the manuscript. No AI tool was used for statistical or data analysis, interpretation of results, or intellectual content generation. All figures and tables were generated by the authors using standard statistical and graphic software (e.g., R, GraphPad Prism, Microsoft Excel); no image was produced by AI tools.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Gemechu Dereje Feyissa, Assistant Professor, Department of Public Health, Faculty of Health Sciences, Rift Valley University, Hangatu District, Dabe Sub-City, Adama 1715, Oromīa, Ethiopia. gemechudereje80@gmail.com
Received: March 9, 2026
Revised: March 19, 2026
Accepted: May 29, 2026
Published online: September 5, 2026
Processing time: 174 Days and 0.9 Hours
Core Tip

Core Tip: Balhara et al pioneer randomized, low-cost dynamic fascial traction via serial Bogota bag tightening, accelerating skin-to-skin closure (9.94 days vs 13 days) and hospital stays in septic open abdomen, bedside feasible, universally accessible, and ideal for low- and middle-income countries overburdened by sepsis, bridging the gap until advanced therapies proliferate.

Write to the Help Desk